MSH6 and colorectal carcinoma: Furthermore, studies [54,55,56] have demonstrated that MSH6 mutations account for 10–15% of all MMR gene mutation in LS-associated EC, and patients with MSH6 mutations exhibit a higher risk of developing EC than colorectal cancer (CRC) [56].